%0 Journal Article %T Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’” %J International Journal of Health Policy and Management %I Kerman University of Medical Sciences %Z 2322-5939 %A Culyer, Anthony J. %D 2019 %\ 12/01/2019 %V 8 %N 12 %P 732-733 %! Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’” %K HTA %K Cost-Effectiveness Analysis %K Scope %K Social Value Judgments %R 10.15171/ijhpm.2019.73 %X Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA). %U https://www.ijhpm.com/article_3664_35e593455ea89bb17587ad76966f77a2.pdf